a

Beim Braunland 1

88416 Ochsenhausen

 a

 a
Analytics - Boehringer Ingelheim Therapeutics in Ochsenhausen, Germany
broad spectrum of physicochemical methods, analyzing characteristics, efficacy and safety of biologicals like antibodies, viral therapeutics, capsids, infectious, genomic virus particles, virus aggregates, analytical capabilities, IPCs, relese testing, process intermediates, drug substances, biological antibodies, viral therapeutics, vaccines, IPCs lab Germany, relese testing lab Germany, drug substances lab Germany, drug products lab Germany, biological antibodies lab Germany, viral therapeutics lab Germany, vaccines Labor Germany, Impurities lab Germany
393
page-template,page-template-full_width,page-template-full_width-php,page,page-id-393,page-child,parent-pageid-397,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-13.6,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-6.7.0,vc_responsive
Analytics

Analytics

Analytical Characterization

Analytics

>> Bioassays | Virology | Microbiology

Analytical Characterization

Boehringer Ingelheim Terapeutics offers a broad spectrum of analytical methods for IPC and release testing of process intermediates, drug substances or drug products of all kind of biologicals like antibodies, viral therapeutics or vaccines.
Physico-Chemical Characterization
Appearance (colour, clarity, visible particles)
pH
Osmolality
Extractable Volume
Viscosity
Residual Moisture
Relative Density
Droplet Size Determination
Droplet Size Determination
Content/Infectious Titer/Potency
Genomic Titer
Total Number Of Virus Particles/Capsids
Infectious Titer (TCID50)
Relative Potency Determination
Purity
Protein Pattern
Aggregate Formation
Impurities
Host Cell Proteins
Host Cell DNA
Residual Benzonase
Residual Formaldehyde
Residual Aluminium
Empty Virus Particles
Safety
Endotoxin
Bioburden
Sterility
Mycoplasma
Mycobacteria
Adventitious Viruses
Our expert teams work in close cooperation with our clients to find optimal solutions for analytical demands. With their long lasting experience in analysis of biologicals, Boehringer Ingelheim Terapeutics designs the most effective study for the clients, which comply with the latest regulatory requirements (e.g. ISO, EP, ASTM, US-FDA).

Protein Biochemestry

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Molecular Biology

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Immunological Assays

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Nanoparticle Tracking Analysis

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Residual DNA Analysis

Boehringer Ingelheim Terapeutics offers a broad spectrum of analytical methods for IPC and release testing of process intermediates, drug substances or drug products of all kind of biologicals like antibodies, viral therapeutics or vaccines.
Physico-Chemical Characterization
Appearance (colour, clarity, visible particles)
pH
Osmolality
Extractable Volume
Viscosity
Residual Moisture
Relative Density
Droplet Size Determination
Droplet Size Determination
Content/Infectious Titer/Potency
Genomic Titer
Total Number Of Virus Particles/Capsids
Infectious Titer (TCID50)
Relative Potency Determination
Purity
Protein Pattern
Aggregate Formation
Impurities
Host Cell Proteins
Host Cell DNA
Residual Benzonase
Residual Formaldehyde
Residual Aluminium
Empty Virus Particles
Safety
Endotoxin
Bioburden
Sterility
Mycoplasma
Mycobacteria
Adventitious Viruses
Our expert teams work in close cooperation with our clients to find optimal solutions for analytical demands. With their long lasting experience in analysis of biologicals, Boehringer Ingelheim Terapeutics designs the most effective study for the clients, which comply with the latest regulatory requirements (e.g. ISO, EP, ASTM, US-FDA).